Medtronic (MDT) is offering its shareholders a swap: hand in Medtronic shares and receive shares of MiniMed, its diabetes ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a standalone company. The new diabetes company will focus on accelerating innovation ...

In just the last few years, diabetes technology has grown exponentially smarter. Top of mind now for many devicemakers is the creation of a truly closed-loop system for insulin delivery—a system often ...

Medtronic announced a spin-off of its diabetes business in May, which will be completed in 2026 and be immediately accretive to its EPS, operating, and gross margins. The spin-off will enable the ...

Medtronic is exiting the diabetes business. The medtech giant said the decision to separate its diabetes business will create a more focused Medtronic, with a more simplified portfolio in high-margin ...

Sheila Denton "brings deep board experience, strong regulatory and transactional judgment, and a proven ability to lead ...

MiniMed Group Inc., a diabetes management firm that will be separated from health care giant Medtronic Plc, filed for an initial public offering, disclosing growing revenue and a shrinking net loss.

– Medtronic today announced its strategic decision to separate its Diabetes business into a new, independent, publicly traded company (“New Diabetes Company”). – The move aims to create a more focused ...

Medtronic must be serious about increasing its penetration in the diabetes management market. The company recently unveiled a collaboration with Samsung related to the development of mobile diabetes ...

The MiniMed 780G system is embedded with an algorithm, dubbed SmartGuard, that takes in blood sugar readings from a connected continuous glucose monitor like Medtronic’s Guardian 4 sensor to create a ...